Eric Lefebvre
CIK 1614741 · View on SEC EDGAR ↗
First SEC filing: June 2, 2020 · Latest: June 2, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 17, 2023 | PLRX | S 10b5-1 | 22,321 | $18.01 | $402,001 | 167,215 Direct | -11.78% | Disposed | -93.4% (price as of 2026-08-19) |
| March 30, 2023 | PLRX | S 10b5-1 | 11,245 | $26.52 | $298,217 | 145,786 Direct | -7.16% | Disposed | -95.5% (price as of 2026-08-19) |
| Jan. 23, 2023 | PLRX | S 10b5-1 | 67,500 | $34.48 | $2,327,400 | 76,926 Direct | -46.74% | Disposed | -96.6% (price as of 2026-08-19) |
| Dec. 20, 2022 | PLRX | S | 10,887 | $19.10 | $207,942 | 144,426 Direct | -7.01% | Disposed | -93.8% (price as of 2026-08-19) |
| Oct. 25, 2022 | PLRX | S 10b5-1 | 5,000 | $25.05 | $125,250 | 133,437 Direct | -3.61% | Disposed | -95.3% (price as of 2026-08-19) |
| June 18, 2021 | PLRX | S 10b5-1 | 22 | $30.23 | $665 | 137,080 Direct | -0.02% | Disposed | -96.1% (price as of 2026-08-19) |
| June 18, 2021 | PLRX | S 10b5-1 | 3,728 | $29.43 | $109,715 | 137,102 Direct | -2.65% | Disposed | -96.0% (price as of 2026-08-19) |
| June 18, 2021 | PLRX | S 10b5-1 | 8,750 | $28.62 | $250,425 | 140,830 Direct | -5.85% | Disposed | -95.9% (price as of 2026-08-19) |
| March 18, 2021 | PLRX | S 10b5-1 | 1,135 | $39.78 | $45,150 | 149,580 Direct | -0.75% | Disposed | -97.0% (price as of 2026-08-19) |
| March 18, 2021 | PLRX | S 10b5-1 | 11,365 | $39.38 | $447,554 | 150,715 Direct | -7.01% | Disposed | -97.0% (price as of 2026-08-19) |
| Dec. 18, 2020 | PLRX | S 10b5-1 | 5,712 | $26.98 | $154,110 | 162,080 Direct | -3.40% | Disposed | -95.6% (price as of 2026-08-19) |
| Dec. 18, 2020 | PLRX | S 10b5-1 | 6,788 | $26.17 | $177,642 | 167,792 Direct | -3.89% | Disposed | -95.5% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 25, 2023 | PLRX | Stock Option (right to buy) | Common Stock (80,000) | $34.65 | Jan. 24, 2033 | 80,000 | Acquired |
| Jan. 23, 2021 | PLRX | Stock Option (right to buy) | Common Stock (73,250) | $26.50 | Jan. 22, 2031 | 73,250 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PLRX
M.D.Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $571,861 | $215,617 | — | — | — | — | $666,486 | $2,724,860 |
| 2024 | $520,312 | — | — | — | $228,937 | — | $13,089 | $2,615,618 |
| 2023 | $500,300 | — | — | — | $220,131 | — | $13,980 | $4,687,061 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.